Live Status Check

NCT06401356 Recruiting Status

Q: What is the status of clinical trial NCT06401356?

NCT06401356 is currently recruiting. This is a PHASE3 study for based on the limited information provided, i cannot determine a specific medical condition. the study only mentions "drug:pelabresib" which is a treatment, not a condition, and there's no actual brief summary content provided (just a localhost url). insufficient information sponsored by Novartis Pharmaceuticals. Status verified from ClinicalTrials.gov.

Q: Where is NCT06401356 recruiting?

NCT06401356 is recruiting at 6 locations across the United States.

Q: How do I enroll in NCT06401356?

To enroll in NCT06401356, check your eligibility on HelloStudys.com and complete the interest form. A coordinator will contact you about next steps.

Real-time enrollment status for this based on the limited information provided, i cannot determine a specific medical condition. the study only mentions "drug:pelabresib" which is a treatment, not a condition, and there's no actual brief summary content provided (just a localhost url). insufficient information clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: August 31, 2026 at 2:30 PM UTC

NCT06401356 Status Summary

NCT Number	NCT06401356
Recruiting Status	Recruiting
Condition	Based on the limited information provided, I cannot determine a specific medical condition. The study only mentions "DRUG:Pelabresib" which is a treatment, not a condition, and there's no actual brief summary content provided (just a localhost URL). Insufficient information
Phase	PHASE3
Target Enrollment	50 participants
Active Locations	6 sites in the US
Sponsor	Novartis Pharmaceuticals
Last Updated on CT.gov	June 11, 2026 (Jun 11, 2026)

About NCT06401356 Enrollment Status

As of August 31, 2026: Clinical trial NCT06401356 is currently recruiting participants. This phase3 study for based on the limited information provided, i cannot determine a specific medical condition. the study only mentions "drug:pelabresib" which is a treatment, not a condition, and there's no actual brief summary content provided (just a localhost url). insufficient information is actively seeking new participants at 6 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06401356

Is NCT06401356 still recruiting?

Yes, NCT06401356 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06401356 recruiting?

This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06401356?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06401356 status last updated?

The official ClinicalTrials.gov record for NCT06401356 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.

Browse More Based on the limited information provided, I cannot determine a specific medical condition. The study only mentions "DRUG:Pelabresib" which is a treatment, not a condition, and there's no actual brief summary content provided (just a localhost URL). Insufficient information Trials

Multiple Myeloma Trials Heart Attack Trials Pulmonary Embolism Trials Essential Tremor Trials Ankylosing Spondylitis Trials Erectile Dysfunction Trials All Conditions →

Ready to Apply?

Check your eligibility for this clinical trial